Switch theme
Sign up to access all valuation multiples
Flerie AB is a pharmaceutical company focusing on immunological diseases with great medical needs for new treatment options. The portfolio of the company includes Immuno-Oncology, metabolic diseases, and biologics development and manufacturing organizations.
2015
7
Last FY Revenue $10K
Last FY EBITDA -$23.3M
$274M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
In the most recent fiscal year, Flerie achieved revenue of $10K and an EBITDA of -$23.3M.
Flerie expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Flerie valuation multiples based on analyst estimates| NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|
| Revenue | XXX | $10K | XXX | XXX | XXX |
| Gross Profit | XXX | n/a | XXX | XXX | XXX |
| Gross Margin | XXX | n/a | XXX | XXX | XXX |
| EBITDA | XXX | -$23.3M | XXX | XXX | XXX |
| EBITDA Margin | XXX | -225900% | XXX | XXX | XXX |
| EBIT | XXX | -$3.9M | XXX | XXX | XXX |
| EBIT Margin | XXX | -37800% | XXX | XXX | XXX |
| Net Profit | XXX | -$23.5M | XXX | XXX | XXX |
| Net Margin | XXX | -228000% | XXX | XXX | XXX |
| Net Debt | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Flerie's stock price is SEK 44 (or $5).
Flerie has current market cap of SEK 3.5B (or $356M), and EV of SEK 2.7B (or $274M).
See Flerie trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $274M | $356M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Flerie has market cap of $356M and EV of $274M.
Flerie's trades at 26531.4x EV/Revenue multiple, and -11.7x EV/EBITDA.
Equity research analysts estimate Flerie's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Flerie's P/E ratio is not available.
See valuation multiples for Flerie and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $356M | XXX | $356M | XXX | XXX | XXX |
| EV (current) | $274M | XXX | $274M | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | 26531.4x | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | -11.7x | XXX | XXX | XXX |
| EV/EBIT | n/a | XXX | -70.2x | XXX | XXX | XXX |
| EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
| P/E | n/a | XXX | -15.2x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | -156.1x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialFlerie's revenue per employee in the last FY averaged $1K, while opex per employee averaged $0.6M for the same period.
Flerie's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Flerie's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Flerie and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | -225900% | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $1K | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.6M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 37900% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Julphar | XXX | XXX | XXX | XXX | XXX | XXX |
| Benevolent AI | XXX | XXX | XXX | XXX | XXX | XXX |
| Galapagos | XXX | XXX | XXX | XXX | XXX | XXX |
| Pharming | XXX | XXX | XXX | XXX | XXX | XXX |
| Vivoryon Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Flerie acquired XXX companies to date.
Last acquisition by Flerie was XXXXXXXX, XXXXX XXXXX XXXXXX . Flerie acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Flerie founded? | Flerie was founded in 2015. |
| Where is Flerie headquartered? | Flerie is headquartered in Sweden. |
| How many employees does Flerie have? | As of today, Flerie has 7 employees. |
| Who is the CEO of Flerie? | Flerie's CEO is Dr. Ted Fjallman, PhD. |
| Is Flerie publicy listed? | Yes, Flerie is a public company listed on STO. |
| What is the stock symbol of Flerie? | Flerie trades under FLERIE ticker. |
| When did Flerie go public? | Flerie went public in 2016. |
| Who are competitors of Flerie? | Similar companies to Flerie include e.g. Julphar, Benevolent AI, Galapagos, Pharming. |
| What is the current market cap of Flerie? | Flerie's current market cap is $356M |
| Is Flerie profitable? | Yes, Flerie is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
